Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lipocine Inc. | 182,668 | reported | 02 Jan 2026 | tx 66+4,198,682−810,978 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Lipocine Inc. | 25,000 | 8.00 USD | deriv |
| 18 Dec 2025 | GRANT_AWARD | Lipocine Inc. | 8,629 | 4.20 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Lipocine Inc. | 16,371 | 4.86 USD | deriv |
| 23 Dec 2024 | GRANT_AWARD | Lipocine Inc. | 26,691 | 4.80 USD | deriv |
| 08 Mar 2024 | GRANT_AWARD | Lipocine Inc. | 4,893 | 0.00 USD | |
| 25 May 2023 | PURCHASE | Lipocine Inc. | 8,706 | 5.03 USD | |
| 24 Mar 2023 | PURCHASE | Lipocine Inc. | 150,000 | 0.32 USD | |
| 17 Mar 2023 | PURCHASE | Lipocine Inc. | 50,000 | 0.33 USD | |
| 03 Jan 2023 | GRANT_AWARD | Lipocine Inc. | 300,000 | 0.41 USD | deriv |
| 22 Dec 2022 | GRANT_AWARD | Lipocine Inc. | 112,500 | 0.41 USD | deriv |
| 14 Nov 2022 | PURCHASE | Lipocine Inc. | 75,000 | 0.39 USD | |
| 27 Sept 2022 | PURCHASE | Lipocine Inc. | 100,000 | 0.41 USD | |
| 16 May 2022 | PURCHASE | Lipocine Inc. | 50,000 | 0.77 USD | |
| 03 Jan 2022 | GRANT_AWARD | Lipocine Inc. | 287,500 | 1.09 USD | deriv |
| 07 Dec 2021 | GRANT_AWARD | Lipocine Inc. | 125,000 | 1.12 USD | deriv |
| 18 Nov 2021 | PURCHASE | Lipocine Inc. | 25,000 | 1.09 USD | first after silence |
| 04 Jan 2021 | GRANT_AWARD | Lipocine Inc. | 275,000 | 1.43 USD | deriv |
| 28 Dec 2020 | OTHER | Lipocine Inc. | 275,000 | 0.00 USD | deriv |
| 16 Dec 2020 | SALE | Lipocine Inc. | 15,000 | 1.35 USD | |
| 16 Dec 2020 | EXERCISE | Lipocine Inc. | 45,000 | 0.00 USD | |
| 15 Dec 2020 | GRANT_AWARD | Lipocine Inc. | 375,000 | 1.37 USD | deriv |
| 16 Dec 2020 | EXERCISE | Lipocine Inc. | 45,000 | 0.00 USD | deriv |
| 05 Dec 2020 | EXERCISE | Lipocine Inc. | 122,978 | 0.00 USD | |
| 04 Dec 2020 | EXERCISE | Lipocine Inc. | 145,000 | 0.00 USD | |
| 04 Dec 2020 | SALE | Lipocine Inc. | 43,500 | 1.57 USD |
2 purchases reported after at least 12 months of silence — most recent on 18 Nov 2021.